Anti-Diabetic Potentials Of Vernonioside E Saponin; A Biochemical Study

Article Sidebar

pdf
Published: Dec 21, 2021

Main Article Content

Daniel E. Uti , Godwin O. Igile , Wilson A. Omang , Grace U. Umoru , Precious A. Udeozor , Uket N. Obeten , Onyinyechi N. Ogbonna , Udu A. Ibiam , Esther U. Alum , Opotu, Rukayat Ohunene , Mordi Joseph Chukwufumnanya , Rowland I. Oplekwu ,Wilson A, Obio

Abstract

Aim:Saponinshave been reported to demonstrate glucose lowering potentials in diabetic conditions. This study was aimed at investigating the effect of Vernonioside E (VE), a steroidal saponin extract from Vernoniaamygdalina(VA) in diabetic rats.
Main Methods: A total of 42 Wistarrats used in the study were distributed into seven (7) groups (n=6). Treatment with varying concentrations of Vernonioside E (VE1, VE2, and VE3), controls, normal (NC) and  diabetic (DC) were given placebo treatments, insulin (5 Iμ/kg b.w) (IP) given to the standard control (SC), and
VA crude extract (400mg/kg b.w) per oral to the other group for 21 days.

Article Details

Issue
Volume: 8 Issue: 4
Section
Articles

All articles published in NVEO are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.